Reported 8 months ago
The pet therapy market shows promising potential, attracting even panel giant AU Optronics' subsidiary Ruisheng Optoelectronics to venture into it by leveraging their experience in X-ray medical technology. With the dual challenge of declining birth rates and an aging population, people are increasingly turning to pet companionship for solace, leading to a surge in pet product demand globally. Many Taiwanese companies are optimistic about pet therapy becoming a new blue ocean in the market, including Eternal Ganges International Biotech, Herborn Biomedical, and SynCore Biopharma, as well as tech company Ruisheng Optoelectronics. This trend is further fueled by the COVID-19 pandemic, pushing the global pet pharmaceutical and treatment demand to grow significantly. The article details how these companies are seizing the opportunity and expanding into the pet therapy industry.
Source: YAHOO